Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Acquisitions & Divestments (2016 - 2025)

CorMedix's Change in Acquisitions & Divestments history spans 11 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 27.99% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $55.3 million, up 14.92%, while the annual FY2025 figure was $55.3 million, 14.92% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $3.6 million at CorMedix, down from $33.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $33.8 million in Q3 2025 and bottomed at $13.0 in Q4 2021.
  • The 5-year median for Change in Acquisitions & Divestments is $8.0 million (2024), against an average of $8.8 million.
  • The largest annual shift saw Change in Acquisitions & Divestments tumbled 100.0% in 2021 before it skyrocketed 68461438.46% in 2022.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $13.0 in 2021, then surged by 68461438.46% to $8.9 million in 2022, then increased by 20.79% to $10.8 million in 2023, then tumbled by 53.49% to $5.0 million in 2024, then dropped by 27.99% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Change in Acquisitions & Divestments are $3.6 million (Q4 2025), $33.8 million (Q3 2025), and $8.1 million (Q2 2025).